Asensus Surgical Inc. (ASXC) stock: EPS estimates from a range of analysts

The closing price of Asensus Surgical Inc. (AMEX: ASXC) was $0.57 for the day, up 0.79% from the previous closing price of $0.57. On the day, 626211 shares were traded. ASXC stock price reached its highest trading level at $0.6044 during the session, while it also had its lowest trading level at $0.5500.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.



Our analysis of ASXC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.80 and its Current Ratio is at 6.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 03 when Biffi Andrea bought 293,077 shares for $0.71 per share. The transaction valued at 207,557 led to the insider holds 492,815 shares of the business.

Starling William N JR sold 27,010 shares of ASXC for $10,804 on Jun 13. The Director now owns 13,846 shares after completing the transaction at $0.40 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASXC now has a Market Capitalization of 141.21M and an Enterprise Value of 90.12M. For the stock, the TTM Price-to-Sale (P/S) ratio is 19.47 while its Price-to-Book (P/B) ratio in mrq is 1.73. Its current Enterprise Value per Revenue stands at 12.88 whereas that against EBITDA is -1.29.

Stock Price History:

Over the past 52 weeks, ASXC has reached a high of $1.18, while it has fallen to a 52-week low of $0.28. The 50-Day Moving Average of the stock is 0.6468, while the 200-Day Moving Average is calculated to be 0.5644.

Shares Statistics:

ASXC traded an average of 928.83K shares per day over the past three months and 695.69k shares per day over the past ten days. A total of 238.28M shares are outstanding, with a floating share count of 234.37M. Insiders hold about 0.10% of the company’s shares, while institutions hold 12.20% stake in the company. Shares short for ASXC as of Apr 27, 2023 were 12.29M with a Short Ratio of 12.29M, compared to 12.49M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 5.13% and a Short% of Float of 5.23%.

Earnings Estimates

The firm’s stock currently is rated by 2 analysts. On average, analysts expect EPS of -$0.08 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.08, while EPS last year was -$0.08. The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.07 and low estimates of -$0.08.

Analysts are recommending an EPS of between -$0.31 and -$0.33 for the fiscal current year, implying an average EPS of -$0.32. EPS for the following year is -$0.27, with 2 analysts recommending between -$0.23 and -$0.32.

Revenue Estimates

It is expected that $90B in revenue will be generated in the current quarter, according to 2 analysts. It ranges from a high estimate of $1.1M to a low estimate of $1.04M. As of the current estimate, Asensus Surgical Inc.’s year-ago sales were $994k, an estimated increase of 7.60% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $1.99M, a decrease of -31.40% less than the figure of $7.60% in the same quarter last year. There is a high estimate of $2.5M for the next quarter, whereas the lowest estimate is $1.47M.

A total of 2 analysts have provided revenue estimates for ASXC’s current fiscal year. The highest revenue estimate was $9.13M, while the lowest revenue estimate was $8.2M, resulting in an average revenue estimate of $8.66M. In the same quarter a year ago, actual revenue was $7.09M, up 22.20% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $16.56M in the next fiscal year. The high estimate is $18.3M and the low estimate is $14.81M. The average revenue growth estimate for next year is up 91.20% from the average revenue estimate for this year.